Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Silk Road Medical Inc.

A novel hybrid carotid artery stenting procedure

Executive Summary

Patients with carotid artery disease currently have two treatment options: traditional surgical repair or transfemoral stenting, but a new minimally invasive therapy that combines the benefits and minimizes the shortcomings of these two choices will soon be available. The ENROUTE procedure from Silk Road Medical consists of a neuroprotection system that reverses blood flow out of the brain to protect the brain from any debris that is liberated during the procedure, and a permanent stent that props open the narrowed carotid artery.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel